BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10862267)

  • 1. Role of progestins in the premenopausal climacteric.
    Schindler AE
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():35-40. PubMed ID: 10862267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-contraceptive benefits of hormonal contraceptives.
    Schindler AE
    Minerva Ginecol; 2010 Aug; 62(4):319-29. PubMed ID: 20827249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contraception using normal dose progestins].
    Pelissier-langbort C
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1099-109. PubMed ID: 12266559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens and progestagens. (Progress--utility, hazards--abuse)].
    Holzmann K
    Munch Med Wochenschr; 1972 Feb; 114(6):217-27. PubMed ID: 5067172
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovariostatic drugs and their use in gynecologic pathology].
    Vaglio N
    Arch Ostet Ginecol; 1967; 72(6):693-706. PubMed ID: 4237146
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
    Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
    Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies with synthetic gestagens].
    Tóth F; Horn B; Primász P
    Orv Hetil; 1969 Jul; 110(30):1723-7. PubMed ID: 5801101
    [No Abstract]   [Full Text] [Related]  

  • 11. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal treatment of climacteric syndrome].
    Dapunt O
    Ther Ggw; 1971 Jan; 110(1):34-50. PubMed ID: 5545646
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer.
    Lai CH; Huang HJ
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):29-34. PubMed ID: 16493257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy for the menopause.
    Gambrell RD; Greenblatt RB
    Geriatrics; 1981 Jul; 36(7):53-61. PubMed ID: 7239166
    [No Abstract]   [Full Text] [Related]  

  • 15. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of menstruation anomalies and preclimacteric disturbances by Duoluton].
    Tscherne E
    Ther Ggw; 1970 Jan; 109(1):93-4 passim. PubMed ID: 5437260
    [No Abstract]   [Full Text] [Related]  

  • 17. Endometriosis: histological and histochemical findings.
    Tóth F; Tóth K; Hidvégi J
    Acta Chir Acad Sci Hung; 1974; 15(1):45-58. PubMed ID: 4136717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities of hormonal therapy in climacteric disorders with special reference to a new method of oral oestrogen treatment (author's transl)].
    Andor J
    Ther Umsch; 1974 Mar; 31(3):182-7. PubMed ID: 4816757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a "conventional" estro-progestinic drug at low dosage in premenopausal and menopausal women].
    Berghella A
    Minerva Ginecol; 1976 May; 28(5):456-7. PubMed ID: 1018827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncontraceptive health benefits of combined oral contraception.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2005; 11(5):513-25. PubMed ID: 16006440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.